Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Antimicrobial report ‘should ring alarm bells’
The report analysed 2017 data on antimicrobial resistance submitted by 28 EU states.
Data shows growing resistance to salmonella and campylobacter 

Antimicrobials used to treat diseases that are transmitted between animals and humans are becoming less effective, according to a report by the European Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC).

EU Commissioner for health and food safety, Vytenis Andriukaitis, said: “The report released today should ring – again – alarm bells. It shows that we are entering into a world where more and more common infections become difficult – or even sometimes impossible – to treat."

The report analysed 2017 data on antimicrobial resistance submitted by 28 EU states. It found that resistance to fluoroquinolones is so high in Campylobacter in some countries that they no longer work for the treatment of severe cases.

Most countries reported that Salmonella in humans is becoming increasingly resistant to fluoroquinolones. Multidrug resistance is high in Salmonella found in humans (28.3%) and animals, particularly in S. Typhimurium.

Mike Catchpole, ECDC’s chief scientist, said. “Now is the time to turn the tide on antimicrobial resistance, if we want to keep antibiotics working. It’s particularly worrying when it comes to combined resistance: even low proportions mean that many thousands of patients across the EU have limited treatment options for severe infections.”

Marta Hugas, EFSA’s chief scientist, said: “We have seen that when Member States have implemented stringent policies, antimicrobial resistance has decreased in animals. Annual reporting by European and national agencies includes noteworthy examples. This should serve as an inspiration for other countries.”

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.